Pliant Therapeuticsinc Stock Price on March 12, 2024
| PLRX Stock | USD 12.88 0.15 1.18% |
If you're considering investing in Pliant Stock, it is important to understand the factors that can impact its price. As of today, the current price of Pliant TherapeuticsInc stands at 12.88, as last reported on the 29th of May, with the highest price reaching 13.02 and the lowest price hitting 12.36 during the day. Pliant TherapeuticsInc maintains Sharpe Ratio (i.e., Efficiency) of -0.0924, which implies the firm had a -0.0924% return per unit of risk over the last 3 months. Pliant TherapeuticsInc exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Pliant TherapeuticsInc's Coefficient Of Variation of (980.58), risk adjusted performance of (0.05), and Variance of 9.84 to confirm the risk estimate we provide.
At this time, Pliant TherapeuticsInc's Total Stockholder Equity is fairly stable compared to the past year. Common Stock Total Equity is likely to rise to 6,038 in 2024, whereas Common Stock is likely to drop 3,143 in 2024. . At this time, Pliant TherapeuticsInc's Price To Sales Ratio is fairly stable compared to the past year. Price Book Value Ratio is likely to rise to 2.36 in 2024, despite the fact that Price Earnings Ratio is likely to grow to (6.26). Pliant Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Pliant |
Sharpe Ratio = -0.0924
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | PLRX |
Estimated Market Risk
| 3.12 actual daily | 27 73% of assets are more volatile |
Expected Return
| -0.29 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.09 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Pliant TherapeuticsInc is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Pliant TherapeuticsInc by adding Pliant TherapeuticsInc to a well-diversified portfolio.
Price Book 1.8024 | Enterprise Value Ebitda (2.34) | Price Sales 539.484 | Shares Float 46.3 M | Wall Street Target Price 41.08 |
Pliant TherapeuticsInc Valuation on March 12, 2024
It is possible to determine the worth of Pliant TherapeuticsInc on a given historical date. On March 12, 2024 Pliant was worth 14.53 at the beginning of the trading date compared to the closed value of 15.14. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Pliant TherapeuticsInc stock. Still, in general, we apply an absolute valuation method to find Pliant TherapeuticsInc's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Pliant TherapeuticsInc where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Pliant TherapeuticsInc's related companies.
| Open | High | Low | Close | Volume | |
| 15.63 | 15.76 | 14.39 | 14.53 | 378,825 | |
03/12/2024 | 14.53 | 15.53 | 14.36 | 15.14 | 542,737 |
| 15.05 | 15.65 | 15.05 | 15.38 | 298,625 |
| Backtest Pliant TherapeuticsInc | | | Pliant TherapeuticsInc History | | | Pliant TherapeuticsInc Valuation | Previous | Next |
Pliant TherapeuticsInc Trading Date Momentum on March 12, 2024
| On March 13 2024 Pliant TherapeuticsInc was traded for 15.38 at the closing time. The top price for the day was 15.65 and the lowest listed price was 15.05 . The trading volume for the day was 298.6 K. The trading history from March 13, 2024 was a factor to the next trading day price jump. The trading delta at closing time against the next closing price was 1.59% . The trading delta at closing time against the current closing price is 0.33% . |
Pliant TherapeuticsInc Fundamentals Correlations and Trends
By evaluating Pliant TherapeuticsInc's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Pliant TherapeuticsInc's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Pliant financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Pliant TherapeuticsInc Stock history
Pliant TherapeuticsInc investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Pliant is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Pliant TherapeuticsInc will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Pliant TherapeuticsInc stock prices may prove useful in developing a viable investing in Pliant TherapeuticsInc
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 58.7 M | 41.1 M | |
| Net Loss | -111 M | -105.4 M |
Pliant TherapeuticsInc Quarterly Net Working Capital |
|
Pliant TherapeuticsInc Stock Technical Analysis
Pliant TherapeuticsInc technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Pliant TherapeuticsInc Period Price Range
Low | March 12, 2024
| High |
14.53 | 15.14 |
Pliant TherapeuticsInc May 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Pliant TherapeuticsInc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Pliant TherapeuticsInc shares will generate the highest return on investment. By undertsting and applying Pliant TherapeuticsInc stock market strength indicators, traders can identify Pliant TherapeuticsInc entry and exit signals to maximize returns
Pliant TherapeuticsInc Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Pliant TherapeuticsInc's price direction in advance. Along with the technical and fundamental analysis of Pliant Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Pliant to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.39) | |||
| Total Risk Alpha | (0.46) | |||
| Treynor Ratio | (0.14) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pliant TherapeuticsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Pliant Stock please use our How to Invest in Pliant TherapeuticsInc guide.You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Complementary Tools for Pliant Stock analysis
When running Pliant TherapeuticsInc's price analysis, check to measure Pliant TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pliant TherapeuticsInc is operating at the current time. Most of Pliant TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Pliant TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pliant TherapeuticsInc's price. Additionally, you may evaluate how the addition of Pliant TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |
Is Pliant TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pliant TherapeuticsInc. If investors know Pliant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pliant TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.86) | Revenue Per Share 0.004 | Quarterly Revenue Growth (1.00) | Return On Assets (0.22) | Return On Equity (0.34) |
The market value of Pliant TherapeuticsInc is measured differently than its book value, which is the value of Pliant that is recorded on the company's balance sheet. Investors also form their own opinion of Pliant TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Pliant TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pliant TherapeuticsInc's market value can be influenced by many factors that don't directly affect Pliant TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pliant TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pliant TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pliant TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.